David Cooper, MD
Pain Medicine · Rockwall, TXNPI 1952584948
Payments from drug & device makers
Across 175 payments — averaging $60.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sobi, Inc$3K
- Medtronic$3K
- Relievant Medsystems, Inc.$1K
- Stryker$885
- Boston Scientific$736
- Nevro Corp.$630
- plus $1K from 10 others
What the payments were for
- Consulting fees$3,05029%
- Travel & lodging$3,69635%
- Food & beverage$3,79836%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sobi, Inc | 1 | $3,050 |
| Medtronic(2 entities) | 53 | $2,889 |
| Relievant Medsystems, Inc. | 10 | $1,143 |
| Stryker | 4 | $885 |
| Boston Scientific | 61 | $736 |
| Nevro Corp. | 10 | $630 |
| Nalu Medical, Inc. | 4 | $442 |
| Saluda Medical Americas, Inc. | 9 | $270 |
| Abbott | 6 | $123 |
| Pfizer | 8 | $121 |
| Pylant Medical | 1 | $87 |
| Scilex Pharmaceuticals Inc. | 3 | $53 |
| SPR Therapeutics, Inc | 1 | $48 |
| Averitas Pharma Inc. | 2 | $41 |
| Foundation Fusion Solutions, LLC | 1 | $15 |
| Stimwave Technologies Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$3,885
- Synagis$3,050
- mild Device Kit$856
- SYNCHROMEDII$773
- INTERSTIM$650
- Senza$383
- Nalu Neurostimulation System$316
How this compares
$10,544 in reported general payments places this provider in the 75th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 31 | $4,670 |
| Gabapentin | 262 | $3,636 |
| Pregabalin | 147 | $3,002 |
| Lidocaine | 18 | $2,734 |
| Duloxetine Hcl | 176 | $2,694 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 126 | $2,643 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 99 | $1,614 |
| Fentanyl | 25 | $1,379 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 61 | $1,377 |
| Methocarbamol | 63 | $1,184 |
| Morphine Sulfate | 45 | $781 |
| Meloxicam | 208 | $744 |
| Tramadol Hcl | 122 | $709 |
| Tizanidine Hcl | 63 | $701 |
| Diclofenac Sodium | 23 | $676 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Rockwall
- Anthony BergRockwall$170K
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Muhammad ZulqarnainDallas$556K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
- David LeimanHouston$281K
- Candice BurnetteSugar Land$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.